Evidence map›Paper›PMID 33312659›Full record

ArticleJournal of environmental health science & engineering2020

Graphene quantum dots based on maltose as a high yield photocatalyst for efficient photodegradation of imipramine in wastewater samples.

Raheleh Hatefi, Ali Mashinchian-Moradi, Habibollah Younesi, Saeed Nojavan

Abstract read
In one paragraph

Article in Journal of environmental health science & engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raheleh HatefiDepartment of Environmental Science, Faculty of Natural Resources, Science and Research Branch, Islamic Azad University (IAU), P.O. Box 14515-775, Tehran, Iran.
Ali Mashinchian-MoradiDepartment of Environmental Science, Faculty of Natural Resources, Science and Research Branch, Islamic Azad University (IAU), P.O. Box 14515-775, Tehran, Iran.ORCID 0000-0002-4273-469X
Habibollah YounesiDepartment of Environmental Science, Faculty of Natural Resources, Tarbiat Modares University, P.O. Box 64414-356, Noor, Iran.
Saeed NojavanDepartment of Analytical Chemistry and Pollutants, Shahid Beheshti University, P.O. Box 19839-4716, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn this work, for the first time, graphene quantum dots (GQDs) based on maltose were fabricated as a new photocatalytic material to the photodegradation of imipramine (as a persistence organic pollutant) under light irradiation.

methodsThe synthesized GQDs were characterized by different instrumentation approaches such as X-ray diffraction (XRD), Fourier transform-infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), nitrogen adsorption/desorption, and transmission electron microscopy (TEM). A Box-Behnken design (BBD) and the response surface methodology (RSM) were applied for the optimization of different factors that affect the overall photocatalytic yield.

resultsUnder the optimized conditions (pH of the sample solution: 2.0; photocatalyst dosage: 0.1 mg mL

conclusionsThe proposed method was successfully applied to degrade the mentioned drug in the real wastewater samples by about 70%. Regarding the mentioned advantages by the proposed method, this new kind of photocatalytic material possesses a strong potential for photodegradation of pollutants in industrial wastewater samples. GRAPHICAL ABSTRACT:

Indexed as

Graphene quantum dotImipramineMaltosePhotocatalystPhotodegradationWastewater treatment

Identifiers

PMID33312659
PMCPMC7721855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.